Why Health Catalyst, Inc.’s (HCAT) Stock Is Down 5.11%
As of Wednesday, November 18, Health Catalyst, Inc.’s HCAT share price has dipped by 5.11%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
| Share Statistics | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $98.2 | $285.4 | 23% |
|
| Shares Out (Mil) | 75.9 | 55.3 | 56% |
|
| Institutional Ownership | 91.5% | 81.3% | 60% |
|
| Float (Mil) | 60.2 | 45.0 | 51% |
|
| Beta | 1.51 | 1.23 | 83% |
|
| Avg Daily Volume (000s) | 395 | 378 | 53% |
|
| Price Change (52-week) |
(42.4%) | 60.1% | 23% |
|
| Growth | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.5% | 13.5% | 60% |
|
| Net Income (5yr) | (9.1%) | 5.4% | 30% |
|
| EPS (5yr) | 2.6% | 15.5% | 35 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (28.6%) | (15.5%) | 21% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 3 | 4 | |
| Current EPS | ($0.053) | ($0.043) | ($0.023) | |
| Month Ago EPS | ($0.043) | ($0.035) | $0.008 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 4 | |
| Three Months Ago EPS | ($0.043) | ($0.039) | $0.040 | |
| Year/Year Chg | (110.0%) | (98.3%) | (103.1%) | |
| Financials | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $272 | $211 | 34% |
|
| Net Income (TTM) (Mil) | ($202) | ($10) | 6% |
|
| EPS (TTM) | ($2.759) | ($0.700) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | $27 | $9 | 42% |
|
| Net Cash Flow (TTM) (Mil) | $13 | $3 | 60% |
|
| Long-Term Debt (Q1) (Mil) | $12 | $15 | 29% |
|
| Enterprise Value (Q1) (Mil) | $46 | $190 | 17% |
|
| Valuation | HCAT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.68 | 1.14 | 17% |
|
| P/E | na | 41.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.5 | na |
|
| Ratios | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 49.5% | 61.3% | 61% |
|
| Net Margin | (74.2%) | (21.7%) | 9% |
|
| ROA | (49.0%) | (15.6%) | 11% |
|
| ROE | (84.6%) | (15.3%) | 10% |
|
| Liabilities to Assets | 38.7% | 32.1% | 29% |
|
| F-Score | 5 | 4 | 50% |
|
Health Catalyst, Inc. did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors